11 Participants Needed

Microbiome and Diet for Colon Cancer

(COLON-MD Trial)

Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Baylor Research Institute
Must be taking: FOLFOX
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The goal of this proposal is to identify how the composition of the gut microbiome and diet interact to impact chemotherapy-induced diarrhea incidence and severity.

Are You a Good Fit for This Trial?

Inclusion Criteria

Stage II/III colon cancer diagnosis
Age >18 and < or equal to 79.
Ability to perform informed consent
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Sample Collection

Patients supply samples of their gut microbiome, dietary intake, and blood samples prior to scheduled colonoscopy or surgery

1-2 weeks

Observational Study

Microbiome and dietary data are collected and analyzed to predict chemotherapy-induced diarrhea

3 years

Follow-up

Participants are monitored for changes in immune markers and risk of chemotherapy-induced diarrhea

4 weeks

What Are the Treatments Tested in This Trial?

Find a Clinic Near You

Who Is Running the Clinical Trial?

Baylor Research Institute

Lead Sponsor

Trials
210
Recruited
205,000+

Baylor University

Collaborator

Trials
65
Recruited
67,600+